| P50 | author | Heidge Fukumasu | Q51558650 |
| P2093 | author name string | D A P C Zuccari | |
| | B V Jardim-Perassi | |
| | G R Varallo | |
| | P A Alexandre | |
| P2860 | cites work | Classification and grading of canine mammary tumors. | Q51512956 |
| | Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model | Q22064565 |
| | HYAL1 overexpression is correlated with the malignant behavior of human breast cancer | Q24313097 |
| | The basics of epithelial-mesenchymal transition | Q24652992 |
| | Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry | Q27026594 |
| | Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 |
| | Molecular portraits of human breast tumours | Q28032461 |
| | Repeated observation of breast tumor subtypes in independent gene expression data sets | Q28131820 |
| | Analyzing real-time PCR data by the comparative C(T) method | Q28131831 |
| | Proteome of Metastatic Canine Mammary Carcinomas: Similarities to and Differences from Human Breast Cancer | Q28295147 |
| | The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas | Q28299374 |
| | Molecular carcinogenesis of canine mammary tumors: news from an old disease | Q28300581 |
| | Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer | Q29619481 |
| | HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer | Q33688043 |
| | Involvement of hyaluronidases in colorectal cancer | Q33694872 |
| | Hyaluronan: A modulator of the tumor microenvironment | Q34516016 |
| | Systems biology and genomics of breast cancer | Q34576377 |
| | Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. | Q36130431 |
| | Five markers useful for the distinction of canine mammary malignancy | Q37113240 |
| | Analysis of different components in the peritumoral tissue microenvironment of colorectal cancer: A potential prospect in tumorigenesis | Q37190790 |
| | From 'differential expression' to 'differential networking' - identification of dysfunctional regulatory networks in diseases | Q37767030 |
| | Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours: part 1. Proliferation, apoptosis and DNA repair | Q38368436 |
| | Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours. Part 2: invasion, angiogenesis, metastasis and therapy | Q38453906 |
| | Genomic and proteomic profiling for cancer diagnosis in dogs | Q38723846 |
| | Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas | Q39910117 |
| | Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification. | Q42439751 |
| | Analysis of a new histological and molecular-based classification of canine mammary neoplasia | Q42444099 |
| | Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics. | Q43989152 |
| | Breast cancer: new concepts in classification | Q48675573 |
| | Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors. | Q51043750 |
| | Evaluation of melatonin treatment in primary culture of canine mammary tumors. | Q51102283 |
| P304 | page(s) | 105393 | |
| P577 | publication date | 2019-10-08 | |
| P1433 | published in | The Veterinary Journal | Q15752615 |
| P1476 | title | Global gene expression profile in canine mammary carcinomas | |
| P478 | volume | 254 | |